Search

Your search keyword '"Koch-Weser J"' showing total 234 results
Start Over Author "Koch-Weser J"
234 results on '"Koch-Weser J"'

202. Enhancement of warfarin-induced hypoprothrombinemia by triclofos.

Author

Sellers EM, Lang M, Koch-Weser J, and Colman RW

Subjects
Administration, Oral, Adult, Chlorine, Dose-Response Relationship, Drug, Drug Interactions, Drug Synergism, Factor VII analysis, Factor X analysis, Humans, Hypnotics and Sedatives administration & dosage, Male, Organophosphorus Compounds administration & dosage, Osmolar Concentration, Prothrombin analysis, Prothrombin Time, Time Factors, Trichloroacetic Acid blood, Hypnotics and Sedatives pharmacology, Hypoprothrombinemias chemically induced, Organophosphorus Compounds pharmacology, Warfarin administration & dosage, Warfarin blood
Published
1972
Full Text
View/download PDF

204. Pharmacokinetic of procainamide in man.

Author

Koch-Weser J

Subjects
Administration, Oral, Arrhythmias, Cardiac drug therapy, Blood Urea Nitrogen, Half-Life, Humans, Injections, Intramuscular, Injections, Intravenous, Intestinal Absorption, Kinetics, Procainamide administration & dosage, Procainamide blood, Procainamide therapeutic use, Procainamide toxicity, Procainamide metabolism
Published
1971
Full Text
View/download PDF

205. Antiarrhythmic prophylaxis in acute myocardial infarction.

Author

Koch-Weser J

Subjects
Acute Disease, Administration, Oral, Arrhythmias, Cardiac etiology, Clinical Trials as Topic, Coronary Care Units, Humans, Injections, Intravenous, Lidocaine administration & dosage, Lidocaine blood, Procainamide administration & dosage, Procainamide blood, Quinidine administration & dosage, Quinidine blood, Arrhythmias, Cardiac prevention & control, Myocardial Infarction complications
Published
1971
Full Text
View/download PDF

206. Letter: Hypotension during administration of angiotensin converting enzyme inhibitor SQ 20,881.

Author

Duhme DW, Sancho J, Athanasoulis C, Haber E, and Koch-Weser J

Subjects
Angiography, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents pharmacology, Blood Pressure drug effects, Drug Interactions, Heart Rate drug effects, Humans, Kidney blood supply, Male, Middle Aged, Pulse drug effects, Renin blood, Angiotensin II antagonists & inhibitors, Hypertension, Renal blood, Hypertension, Renal diagnosis, Hypertension, Renal diagnostic imaging, Hypotension chemically induced, Oligopeptides adverse effects
Published
1974
Full Text
View/download PDF

208. Effectiveness of bretylium tosylate against refractory ventricular arrhythmias.

Author

Bernstein JG and Koch-Weser J

Subjects
Action Potentials drug effects, Administration, Oral, Adult, Aged, Bretylium Compounds administration & dosage, Bretylium Compounds adverse effects, Clinical Trials as Topic, Drug Resistance, Evaluation Studies as Topic, Female, Follow-Up Studies, Heart Conduction System drug effects, Humans, Hypertension chemically induced, Hypotension, Orthostatic chemically induced, Male, Middle Aged, Movement Disorders chemically induced, Norepinephrine metabolism, Sympathetic Nervous System drug effects, Tachycardia drug therapy, Tosyl Compounds therapeutic use, Ventricular Fibrillation drug therapy, Vomiting chemically induced, Arrhythmias, Cardiac drug therapy, Bretylium Compounds therapeutic use, Heart Ventricles physiopathology
Published
1972
Full Text
View/download PDF

210. Drug therapy. Serum drug concentrations as therapeutic guides.

Author

Koch-Weser J

Subjects
Binding Sites, Drug Therapy, Drug Tolerance, Humans, Pharmaceutical Preparations blood, Pharmaceutical Preparations metabolism, Pharmacology, Phenytoin blood, Protein Binding, Serum Albumin metabolism, Pharmaceutical Preparations administration & dosage
Published
1972
Full Text
View/download PDF

212. Interaction of chloral hydrate and ethanol in man. I. Metabolism.

Author

Sellers EM, Lang M, Koch-Weser J, LeBlanc E, and Kalant H

Subjects
Acetaldehyde blood, Adult, Alcohol Oxidoreductases, Animals, Carbon Isotopes, Chloral Hydrate blood, Chloral Hydrate pharmacology, Chloral Hydrate urine, Clinical Trials as Topic, Drug Interactions, Ethanol blood, Ethanol urine, Horses, Humans, Kinetics, Liver enzymology, Male, Rats, Spectrophotometry, Trichloroacetic Acid blood, Trichloroacetic Acid pharmacology, Chloral Hydrate metabolism, Ethanol metabolism
Published
1972
Full Text
View/download PDF

213. Relation of hydralazine plasma concentration to dosage and hypotensive action.

Author

Zacest R and Koch-Weser J

Subjects
Acylation, Administration, Oral, Adult, Blood Pressure drug effects, Female, Humans, Hydralazine administration & dosage, Hydralazine therapeutic use, Hypertension blood, Hypertension drug therapy, Male, Middle Aged, Phenotype, Propranolol pharmacology, Sulfamethazine urine, Time Factors, Hydralazine blood
Published
1972
Full Text
View/download PDF

214. Beta-receptor blockade and myocardial effects of cardiac glycosides.

Author

Koch-Weser J

Subjects
Adrenergic beta-Antagonists pharmacology, Animals, Cats, Chickens, Culture Techniques, Digoxin antagonists & inhibitors, Dogs, Electric Stimulation, Guinea Pigs, Heart Atria drug effects, Heart Conduction System drug effects, Myocardium metabolism, Neurosecretion drug effects, Norepinephrine antagonists & inhibitors, Norepinephrine physiology, Ouabain antagonists & inhibitors, Papillary Muscles drug effects, Rabbits, Species Specificity, Strophanthins antagonists & inhibitors, Tyramine antagonists & inhibitors, Cardiac Glycosides antagonists & inhibitors, Heart drug effects, Propranolol pharmacology
Published
1971
Full Text
View/download PDF

215. Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program.

Author

Greenblatt DJ and Koch-Weser J

Subjects
Adult, Aged, Blood Urea Nitrogen, Coma chemically induced, Dehydration chemically induced, Diarrhea chemically induced, Female, Gynecomastia chemically induced, Headache chemically induced, Heart Failure drug therapy, Humans, Hyperkalemia chemically induced, Hypertension drug therapy, Hyponatremia chemically induced, Liver Cirrhosis drug therapy, Male, Middle Aged, Nausea chemically induced, Neoplasms drug therapy, Potassium Chloride therapeutic use, Skin Diseases chemically induced, Spironolactone therapeutic use, Vomiting chemically induced, Spironolactone adverse effects
Published
1973
Full Text
View/download PDF

216. Survival after massive procainamide ingestion.

Author

Villalba-Pimentel L, Epstein LM, Sellers EM, Foster JR, Bennion LJ, Nadler LM, Bough EW, and Koch-Weser J

Subjects
Aged, Biotransformation, Depression, Chemical, Electrocardiography, Epinephrine therapeutic use, Heart Conduction System drug effects, Humans, Hydrogen-Ion Concentration, Hypotension chemically induced, Isoproterenol therapeutic use, Male, Pacemaker, Artificial, Peritoneal Dialysis, Procainamide blood, Procainamide pharmacology, Procainamide urine, Procainamide poisoning
Published
1973
Full Text
View/download PDF

219. Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Author

Greenblatt DJ and Koch-Weser J

Subjects
Adrenergic beta-Antagonists therapeutic use, Bradycardia chemically induced, Central Nervous System drug effects, Depression chemically induced, Heart drug effects, Heart Failure chemically induced, Hematologic Diseases chemically induced, Humans, Hypoglycemia chemically induced, Hypotension chemically induced, Propranolol administration & dosage, Propranolol adverse effects, Respiration drug effects, Adrenergic beta-Antagonists adverse effects
Published
1974
Full Text
View/download PDF

221. Vasodilation for vasospastic hypertension.

Author

Koch-Weser J

Subjects
Diuretics therapeutic use, Humans, Hypertension physiopathology, Hypertension, Malignant drug therapy, Minoxidil adverse effects, Minoxidil antagonists & inhibitors, Minoxidil therapeutic use, Propranolol pharmacology, Propranolol therapeutic use, Vascular Resistance drug effects, Vasodilator Agents pharmacology, Hypertension drug therapy, Vasodilator Agents therapeutic use
Published
1973
Full Text
View/download PDF

222. Protein binding and vascular activity of diazoxide.

Author

Sellers EM and Koch-Weser J

Subjects
Arteries drug effects, Binding Sites, Diazoxide administration & dosage, Diazoxide adverse effects, Diazoxide blood, Diazoxide therapeutic use, Humans, Hypertension drug therapy, In Vitro Techniques, Injections, Intravenous, Time Factors, Diazoxide metabolism, Diazoxide pharmacology, Protein Binding, Serum Albumin metabolism, Vasodilator Agents pharmacology
Published
1969
Full Text
View/download PDF

223. Coumarin necrosis.

Author

Koch-Weser J

Subjects
Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Necrosis, Coumarins adverse effects, Skin Diseases chemically induced
Published
1968
Full Text
View/download PDF

224. Oral anticoagulant therapy.

Author

Sellers EM and Koch-Weser J

Subjects
Administration, Oral, Anti-Bacterial Agents administration & dosage, Anticoagulants administration & dosage, Chloral Hydrate administration & dosage, Humans, Phenytoin administration & dosage, Vitamin K biosynthesis, Warfarin administration & dosage, Anticoagulants therapeutic use, Drug Synergism
Published
1972

228. Sympathetic activity in essential hypertension.

Author

Koch-Weser J

Subjects
Antihypertensive Agents pharmacology, Blood Pressure drug effects, Ganglionic Blockers pharmacology, Hemodynamics, Humans, Hypertension blood, Hypertension drug therapy, Hypertension metabolism, Hypertension urine, Norepinephrine blood, Norepinephrine metabolism, Norepinephrine urine, Sympathetic Nervous System drug effects, Hypertension physiopathology, Sympathetic Nervous System physiopathology
Published
1973
Full Text
View/download PDF

229. Correlation of pathophysiology and pharmacotherapy in primary hypertension.

Author

Koch-Weser J

Subjects
Blood Pressure, Cardiac Output, Cardiac Volume, Diuretics therapeutic use, Furosemide therapeutic use, Guanethidine therapeutic use, Heart Failure etiology, Humans, Methyldopa therapeutic use, Norepinephrine blood, Plasma Volume, Propranolol therapeutic use, Renin blood, Reserpine therapeutic use, Spironolactone therapeutic use, Vascular Resistance, Vasodilator Agents therapeutic use, Hypertension complications, Hypertension drug therapy, Hypertension physiopathology
Published
1973
Full Text
View/download PDF

230. Influence of intravenous injection rate on protein binding and vascular activity of diazoxide.

Author

Sellers EM and Koch-Weser J

Subjects
Animals, Binding Sites, Binding, Competitive, Blood Pressure drug effects, Cattle, Computers, Diazoxide administration & dosage, Diazoxide pharmacology, Dogs, Half-Life, Horses, Humans, Injections, Intravenous, Kinetics, Models, Biological, Rabbits, Rats, Serum Albumin metabolism, Serum Albumin, Bovine metabolism, Sheep, Species Specificity, Swine, Time Factors, Diazoxide blood, Protein Binding
Published
1973
Full Text
View/download PDF

231. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.

Author

Sellers EM and Koch-Weser J

Subjects
Binding Sites, Blood Coagulation drug effects, Chloral Hydrate administration & dosage, Chloral Hydrate adverse effects, Chloral Hydrate metabolism, Chloral Hydrate therapeutic use, Depression, Chemical, Drug Synergism, Humans, Hypoprothrombinemias prevention & control, Male, Protein Binding, Prothrombin analysis, Prothrombin Time, Serum Albumin metabolism, Trichloroacetic Acid blood, Trichloroacetic Acid metabolism, Warfarin administration & dosage, Warfarin blood, Warfarin metabolism, Chloral Hydrate pharmacology, Hypoprothrombinemias chemically induced, Warfarin pharmacology
Published
1970
Full Text
View/download PDF

233. Chloral hydrate and warfarin therapy.

Author

Koch-Weser J, Sellers EM, Udall JA, Griner PF, and Rickles FR

Subjects
Chloral Hydrate adverse effects, Drug Synergism, Hypoprothrombinemias chemically induced, Warfarin adverse effects
Published
1971
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results